Vaxxas

Hamilton, Australia · Founded 2011 · Privately Held (backing)

Developer of a needle-free vaccine delivery system designed to enhance the performance of existing and next-generation vaccines. Vaxxas is based in Hamilton, Australia and was founded in 2011. Its last reported valuation was $236 million in Aug 2025. It has raised $154 million.

Last reported valuation
$235.6M
Oct 2026
Priced at
—
Total raised
$154.3M
Last round
—

Who backs Vaxxas?

22 investors
InvestorType
Gates FoundationOther
QICOther
Wellcome TrustOther
Brandon CapitalVenture capital
SPRIM Global InvestmentsOther
OneVenturesVenture capital
Eli Lilly and Company FoundationOther
Prisma (Australia)Family office
HealthCare VenturesVenture capital
LGT Crestone Wealth ManagementOther
+ 12 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Vaxxas investors

22 investors are on record for Vaxxas, including Gates Foundation, QIC, Wellcome Trust and Brandon Capital.

Free account
More of Vaxxas with a free account
  • ·The complete investor list: 22 names
  • ·Watch Vaxxas: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 22 firms already write checks for companies like Vaxxas. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View